ROGER N ROSENBERG
Neurology at Harry Hines Blvd, Dallas, TX

License number
Texas E2336
Category
Neurology
Type
Neurology
Address
Address
5323 Harry Hines Blvd, Dallas, TX 75390
Phone
(214) 645-8800
(214) 645-8801 (Fax)

Personal information

See more information about ROGER N ROSENBERG at radaris.com
Name
Address
Phone
Roger N Rosenberg, age 85
4425 Wildwood Rd, Dallas, TX 75209
(214) 351-2647
(214) 351-6395
Roger Rosenberg
1700 Pacific Ave, Dallas, TX 75201
(214) 648-3239
Roger Rosenberg
5323 Harry Hines Blvd, Dallas, TX 75390
(214) 648-3239
Roger Rosenberg
Dallas, TX
(214) 351-2647

Professional information

Roger Rosenberg Photo 1

Professor Of Neurology At Ut Southwestern

Position:
Professor of Neurology at UT Southwestern
Location:
Dallas/Fort Worth Area
Industry:
Research
Work:
UT Southwestern - Professor of Neurology


Roger N Rosenberg Photo 2

Dr. Roger N Rosenberg, Dallas TX - MD (Doctor of Medicine)

Specialties:
Neuropsychiatry (Neurology)
Address:
UT Southwestern Neurology Clnc
5303 Harry Hines Blvd SUITE 10, Dallas 75390
(214) 645-8800 (Phone)
5959 Harry Hines Blvd, Dallas 75235
(214) 648-9574 (Phone)
Certifications:
Neurology, 1971
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
UT Southwestern Neurology Clnc
5303 Harry Hines Blvd SUITE 10, Dallas 75390
5959 Harry Hines Blvd, Dallas 75235
Ut Southwestern University Hospital
5909 Harry Hines Blvd, Dallas 75390
Education:
Medical School
Northwestern University The Feinberg School Of Medicine
Graduated: 1964
Harvard Med Serv/Beth Israel Hospital
Graduated: 1965
Presby Hospital Columbia P&S
Graduated: 1968


Roger Rosenberg Photo 3

Amyloid Β Gene Vaccines

US Patent:
7479550, Jan 20, 2009
Filed:
Jun 2, 2006
Appl. No.:
11/445936
Inventors:
Roger N. Rosenberg - Dallas TX, US
Stephen A. Johnston - Tempe AZ, US
Assignee:
The Board of Regents of the University of Texas System - Austin TX
International Classification:
C07H 21/04, A01N 43/04, A61K 39/12, A61K 39/00
US Classification:
536 231, 514 44, 4241921, 4241861
Abstract:
The invention generally concerns compositions and methods for genetic vaccination with amyloid beta (Aβ) protein. Such vaccines may provide effective treatment for neurodegenerative disease such as Alzheimer's disease. Vaccination methods are can be used to induce a Th2 type immune response directed to Aβ. This immune response id shown to substantially reduce Aβ concentration and Aβ plaque size in an Alzheimer's model system.